Chiron
Executive Summary
Files with SEC for an offering of 2.1 mil. shares of common stock consisting of the sale of 1.5 mil. shares in the U.S. by underwriters PaineWebber, Robertson Stephens and Montgomery Securities, who will be joined by Swiss Bank Corporation Investment Banking for a European offering of 600,000 shares. The new offering would be worth approximately $ 36 mil. at the stock's recent market price of 17-1/4.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.